-
公开(公告)号:US11304954B2
公开(公告)日:2022-04-19
申请号:US16955162
申请日:2018-12-19
发明人: Daniel Kenneth Bonner , Ketki Karanam , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Rishab R. Shyam , Jamie Simpson , Natalie Trevaskis
IPC分类号: C07D413/12 , A61K31/5377 , A61K47/54 , A61P37/06
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US11938137B2
公开(公告)日:2024-03-26
申请号:US17586515
申请日:2022-01-27
发明人: Daniel Kenneth Bonner , Ketki Karanam , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Rishab R. Shyam , Jamie Simpson , Natalie Trevaskis
IPC分类号: A61K31/5377 , A61K47/54 , A61P37/06 , C07D413/12
CPC分类号: A61K31/5377 , A61K47/542 , A61P37/06 , C07D413/12
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20220001015A1
公开(公告)日:2022-01-06
申请号:US16642794
申请日:2018-08-29
发明人: Daniel Kenneth Bonner , Ketki Karanam , James T. Mutamba , Rishab R. Shyam , Jamie Simpson , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Natalie Trevaskis
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a provided lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US11975073B2
公开(公告)日:2024-05-07
申请号:US18341519
申请日:2023-06-26
发明人: Daniel Kenneth Bonner , Rishab R. Shyam , Jamie Simpson , Christopher John Porter , Natalie Trevaskis , Tim Quach , Sifei Han , Luojuan Hu
IPC分类号: A61K47/55 , A61K9/00 , A61K31/573 , A61K47/54
CPC分类号: A61K47/55 , A61K9/0053 , A61K31/573 , A61K47/542
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US11883497B2
公开(公告)日:2024-01-30
申请号:US16642794
申请日:2018-08-29
发明人: Daniel Kenneth Bonner , Ketki Karanam , James T. Mutamba , Rishab R. Shyam , Jamie Simpson , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Natalie Trevaskis
CPC分类号: A61K47/543 , A61K45/06
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a provided lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20220395513A1
公开(公告)日:2022-12-15
申请号:US17881458
申请日:2022-08-04
发明人: Daniel Kenneth Bonner , Rishab R. Shyam , Jamie Simpson , Christopher John Porter , Natalie Trevaskis , Tim Quach , Sifei Han , Luojuan Hu
IPC分类号: A61K31/573 , A61K47/54
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20240245788A1
公开(公告)日:2024-07-25
申请号:US18409546
申请日:2024-01-10
发明人: Daniel Kenneth Bonner , Rishab R. Shyam , Jamie Simpson , Christopher John Porter , Natalie Trevaskis , Tim Quach , Sifei Han , Luojuan Hu
IPC分类号: A61K47/55 , A61K9/00 , A61K31/573 , A61K47/54
CPC分类号: A61K47/55 , A61K9/0053 , A61K31/573 , A61K47/542
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20240207411A1
公开(公告)日:2024-06-27
申请号:US18425761
申请日:2024-01-29
发明人: Daniel Kenneth Bonner , Ketki Karanam , James Tendai Mutamba , Rishab R. Shyam , Jamie Simpson , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Natalie Trevaskis
CPC分类号: A61K47/543 , A61K45/06
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a provided lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20220143038A1
公开(公告)日:2022-05-12
申请号:US17586515
申请日:2022-01-27
发明人: Daniel Kenneth Bonner , Ketki Karanam , Sifei Han , Luojuan Hu , Christopher John Hamilton Porter , Tim Quach , Rishab R. Shyam , Jamie Simpson , Natalie Trevaskis
IPC分类号: A61K31/5377 , A61K47/54 , A61P37/06 , C07D413/12
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
公开(公告)号:US20230338552A1
公开(公告)日:2023-10-26
申请号:US18341519
申请日:2023-06-26
发明人: Daniel Kenneth Bonner , Rishab R. Shyam , Jamie Simpson , Christopher John Porter , Natalie Trevaskis , Tim Quach , Sifei Han , Luojuan Hu
IPC分类号: A61K47/55 , A61K31/573 , A61K9/00 , A61K47/54
CPC分类号: A61K47/55 , A61K31/573 , A61K9/0053 , A61K47/542
摘要: The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
-
-
-
-
-
-
-
-
-